Ethan Mann

Ethan Mann is an experienced leader in the biotech and pharmaceutical sectors, currently serving as Chief Executive Officer at OrganiShield and Venture Partner at LemVega Biotech Venture Fund while also holding the position of Managing Partner at Blacktip Ventures. With a background in stem cell research and commercialization, Mann previously led Validus Cellular Therapeutics as Chief Executive Officer and played pivotal roles at Sharklet Technologies, where responsibilities included managing operations and leading commercialization efforts. Academic qualifications include a Ph.D. in Microbiology, an MBA in Finance, and a BS in Chemistry, underscoring a strong blend of scientific expertise and business acumen.